The Quality Lowdown: The Effort Required To Stem Substandard, Illegitimate, Unapproved Drugs
Executive Summary
As stakeholders in the US pharmaceutical distribution chain prepare to coordinate against suspect drugs, the world’s leading inspectorates collaborate on good distribution practices.
You may also be interested in...
For US FDA, ‘History Is Again Repeating’ With International Diethylene Glycol Poisoning Outbreak
CDER manufacturing quality director notes origin of Food, Drug and Cosmetic Act in 1938 is linked to DEG/EG poisoning. FDA says current outbreak in at least seven countries “one of the largest epidemics of DEG and EG poisoning in history.”
AAM Calls For Congress And FDA To End Shortages By Easing Up On Generics Quality, Pricing
Remote inspection alternatives could allow quicker resolution of quality issues that are holding up US imports, says association for generic drug manufacturers. AAM adds that adjusting a Medicaid inflation penalty could relieve unfair price pressures.
Quality Street: India Needs A Frances Kelsey, Many Of Her Kind
Scrip delves into some of India’s critical compliance and quality challenges and efforts to address those.